Lv4
590 积分 2024-03-21 加入
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2小时前
待确认
2024 ESC Guidelines for the management of chronic coronary syndromes
2小时前
待确认
Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC
18天前
已完结
Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials
20天前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
20天前
已完结
Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation
20天前
已完结
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
20天前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
21天前
已完结
SAFETY OUTCOMES BETWEEN SECOND-LINE OF ANTIHYPERGLYCEMIC AGENTS CLASSES IN OLDER ADULTS WITH TYPE 2 DIABETES: INSIGHTS FROM THE LARGE-SCALE EVIDENCE GENERATION AND EVALUATION ACROSS A NETWORK OF DATABASE
22天前
已完结
Cardiometabolic Effects of Tirzepatide in Type 2 Diabetes: Individual Variation and Relationship to Cardiovascular Outcomes
23天前
已完结
皖公网安备34019202002308
